SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR/VOXILAPREVIR-BASED REGIMENS FOR THE TREATMENT OF HCV GENOTYPE 1-6: RESULTS OF THE HCV-TARGET COHORT

Zeuzem, S; Sulkowski, MS; Lim, JK; Morelli, G; Khalili, M; Brown, RS; Ben-Ari, Z; Park, JS; Reddy, KR; Shiffman, ML; Dong, MC; Vainorius, M; Fried, MW; Nelson, DR; Terrault, N

HEPATOLOGY, 2019; 70 (): 939A